Business Context and Reporting Period
Company: IRIDEX Corporation (IRIX)
Filing Type: Form 8-K (Current Report)
Date of Report: June 27, 2024
Reporting Period: Event-based report regarding listing status as of June 27, 2024.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels. The only financial metric disclosed is the Market Value of Listed Securities (MVLS), which was below the minimum requirement of $50,000,000 for the last 30 consecutive business days.
Material Changes
- Listing Status Change: The Company received a notification of non-compliance from Nasdaq regarding the Market Value of Listed Securities (MVLS) requirement for The Nasdaq Global Market.
- Transfer Initiation: IRIDEX has begun the process to transfer its listing from The Nasdaq Global Market to The Nasdaq Capital Market to regain compliance.
- Trading Continuity: The notice has no immediate effect on trading; the stock will continue to trade under the symbol "IRIX" pending the transfer application approval.
Guidance, Outlook, and Risks
Management Commentary: Management intends to become compliant with continued listing requirements by transferring to The Nasdaq Capital Market. The Company expects the transfer application to be accepted.
Risks and Uncertainties: The filing includes standard forward-looking statement disclaimers. Risks include the possibility that actual results may differ from expectations regarding the listing transfer. There is no specific financial guidance or outlook provided in this document.
Investor Verification Checklist
- Verify the current Market Value of Listed Securities (MVLS) to confirm if it remains below the $50 million threshold for the Global Market.
- Confirm the status of the transfer application to The Nasdaq Capital Market.
- Review recent 10-Q or 10-K filings for the underlying financial performance (revenue, cash flow) that may have contributed to the decline in market value.
- Monitor for any further communications from Nasdaq regarding the listing transfer approval or potential delisting if the transfer is not successful.